Aortic Dissection — Stanford Classification, Diagnosis, and Emergency Management

Aortic dissection is a life-threatening condition characterized by a tear in the intimal layer of the aorta, allowing blood to enter the medial layer and create a false lumen. This separates the aortic wall layers, potentially compromising blood flow to vital organs and causing aortic rupture.

[KEY_CONCEPT] The Stanford Classification System is the most clinically relevant classification for aortic dissection:

DeBakey Classification provides additional anatomical detail:

• Type I: Originates in ascending aorta, extends to arch and beyond
• Type II: Limited to ascending aorta only
• Type III: Originates distal to left subclavian artery

[HIGH_YIELD] Type A dissections account for 60-70% of cases and carry higher mortality due to potential complications including:

• Aortic regurgitation
• Coronary artery compromise
• Cardiac tamponade
• Stroke from carotid involvement

Epidemiology:

• Incidence: 3-4 per 100,000 person-years
• Peak age: 60-80 years
• Male predominance (2-5:1)
• Risk factors: Hypertension (most important), connective tissue disorders (Marfan syndrome, Ehlers-Danlos), bicuspid aortic valve, coarctation of aorta, pregnancy, cocaine use

[CLINICAL_PEARL] Acute dissection occurs within 14 days of symptom onset, while chronic dissection is >14 days. The distinction is crucial as chronic Type B dissections may require different management approaches.

Classic Presentation: The hallmark symptom is severe, tearing chest pain with abrupt onset described as "the worst pain of my life." Pain characteristics vary by dissection location:

Type A Dissection Pain:

• Anterior chest pain radiating to back
• May involve neck, jaw, or arms
• Associated with syncope (20-30% of cases)

Type B Dissection Pain:

• Interscapular back pain
• May radiate to abdomen or flanks
• Less likely to cause syncope

[HIGH_YIELD] Physical Examination Findings:

Cardiovascular:

• Blood pressure differential >20 mmHg between arms (found in 15-30%)
• New aortic regurgitation murmur (Type A)
• Pulse deficits in extremities (25-50% of cases)
• Muffled heart sounds if pericardial effusion present

Neurological:

• Stroke or focal neurological deficits (5-10% Type A)
• Spinal cord ischemia with paraplegia (Type B)
• Altered mental status

Other Manifestations:

• Horner syndrome (compression of sympathetic chain)
• Superior vena cava syndrome
• Hoarseness (recurrent laryngeal nerve compression)
• Lower extremity ischemia

[CLINICAL_PEARL] Painless dissection occurs in 5-15% of cases, particularly in elderly patients or those with diabetes. These patients may present with:

• Syncope alone
• Acute heart failure
• Stroke without chest pain
• Acute limb ischemia

Risk Stratification by Complications:

[KEY_CONCEPT] The absence of classic findings does not exclude aortic dissection. Maintain high clinical suspicion in patients with risk factors and compatible symptoms.

Initial Assessment Algorithm:

Clinical Suspicion for Aortic Dissection | v High Probability (>60%) → Immediate CTA/TEE | v Intermediate (20-60%) → D-dimer + Risk Score | v Low Probability (<20%) → Alternative diagnosis

[HIGH_YIELD] Aortic Dissection Detection Risk Score (ADD-RS):

High-risk conditions (1 point each):

• Marfan syndrome or connective tissue disease
• Family history of aortic disease
• Known aortic valve disease
• Recent aortic manipulation
• Chest/back/abdominal pain described as tearing/ripping

High-risk features (1 point each):

• Blood pressure differential >20 mmHg
• Pulse deficit
• Focal neurological deficit
• New murmur of aortic insufficiency
• Hypotension or shock

Score ≤1: Low risk, consider D-dimer Score ≥2: High risk, proceed to imaging

Laboratory Studies:

• D-dimer: Negative predictive value >95% when <500 ng/mL in low-risk patients
• Troponin: May be elevated if coronary involvement
• CBC, CMP, PT/PTT: Baseline before anticoagulation decisions
• Type and crossmatch: Prepare for potential surgery

[KEY_CONCEPT] Imaging Modalities Comparison:

[CLINICAL_PEARL] CTA is first-line imaging in hemodynamically stable patients. Key findings include:

• Intimal flap separating true and false lumens
• False lumen thrombosis
• Branch vessel involvement
• Pericardial effusion (suggests impending rupture)

ECG Findings:

• Usually non-specific ST-T changes
• ST elevation may indicate coronary involvement (Type A)
• LVH pattern suggests chronic hypertension

Chest X-ray Findings:

• Widened mediastinum (>8 cm at aortic knob)
• Abnormal aortic contour
• Pleural effusion (usually left-sided)
• Normal chest X-ray does not exclude dissection (12-15% have normal CXR)

Immediate Stabilization Protocol:

Aortic Dissection Confirmed | v Type A → Emergency Surgery Consultation | v Type B → Medical Management | v BP Control: Target SBP 100-120 mmHg | v Heart Rate Control: Target <60 bpm | v Pain Control + Serial Monitoring

[HIGH_YIELD] Medical Management - First-Line Agents:

Beta-blockers (First Choice):

• Esmolol: 500 mcg/kg IV bolus, then 50-300 mcg/kg/min
• Metoprolol: 5-15 mg IV q6h
• Propranolol: 1-3 mg IV q4h

Vasodilators (After Beta-blockade):

• Nicardipine: 5-15 mg/hr IV
• Clevidipine: 1-32 mg/hr IV
• Enalaprilat: 0.625-5 mg IV q6h

[CLINICAL_PEARL] Never give vasodilators without beta-blockers first - this can cause reflex tachycardia and increased dP/dt, worsening the dissection.

Surgical Indications:

Type A (Emergent Surgery):

• All Type A dissections unless prohibitive surgical risk
• Goal: Replace ascending aorta ± aortic valve
• Timing: Within 6-12 hours of presentation

Type B (Surgical/Endovascular Indications):

• Complicated Type B:
  • Refractory pain
  • Uncontrolled hypertension
  • End-organ malperfusion
  • Aortic expansion >5mm in 6 months
  • Rupture or impending rupture

[KEY_CONCEPT] TEVAR (Thoracic Endovascular Aortic Repair) is preferred over open surgery for complicated Type B dissections when anatomically feasible.

Contraindications to Surgery:

Pain Management:

• Morphine: 2-4 mg IV q2-4h PRN
• Avoid NSAIDs (interfere with platelet function)
• Fentanyl for patients with hemodynamic instability

Monitoring Parameters:

• Continuous cardiac monitoring
• Blood pressure in both arms
• Hourly neurological checks
• Urine output (goal >0.5 mL/kg/hr)
• Serial imaging if clinical deterioration

[HIGH_YIELD] Perioperative Considerations:

• Blood products: Type-specific blood available
• Coagulation management: Reverse anticoagulation if present
• Neuroprotection: Hypothermia, cerebral perfusion strategies
• Spinal cord protection: CSF drainage for extensive repairs

Acute Complications by Type:

[HIGH_YIELD] Type A Complications:

• Cardiac tamponade (8-10%): Most common cause of death
• Acute aortic regurgitation (40-76%): Due to disruption of aortic valve apparatus
• Myocardial infarction (1-2%): RCA involvement more common than LAD
• Stroke (6-10%): Carotid or vertebral artery involvement
• Visceral malperfusion (15-20%): Renal, mesenteric, limb ischemia

Type B Complications:

• Rupture (3-5%): Free rupture into pleural space or retroperitoneum
• Visceral malperfusion (25-30%): More common than Type A
• Spinal cord ischemia (2-5%): Anterior spinal artery syndrome
• Renal failure (10-15%): Direct renal artery involvement

Malperfusion Syndromes:

[CLINICAL_PEARL] Static vs. Dynamic Obstruction:

• Static: Intimal flap occludes branch vessel origin
• Dynamic: False lumen expansion compresses true lumen
• Dynamic obstruction may improve with medical management

Mortality Rates:

Type A Dissection:

• Without surgery: 1-2% per hour in first 48 hours
• With surgery: 10-25% perioperative mortality
• Overall hospital mortality: 15-30%

Type B Dissection:

• Uncomplicated: 2-5% hospital mortality
• Complicated: 10-20% hospital mortality
• With TEVAR: 5-15% perioperative mortality

[KEY_CONCEPT] Long-term Outcomes:

Surveillance Requirements:

• Imaging schedule: 1, 3, 6, 12 months, then annually
• Target parameters:
  • Aortic diameter growth <5mm/year
  • No new dissection or aneurysm formation
  • Maintained organ perfusion

Medical Management for Life:

• Blood pressure control: Target <130/80 mmHg
• Beta-blockers: Continue indefinitely unless contraindicated
• Smoking cessation: Critical for preventing progression
• Activity restrictions: Avoid heavy lifting >50 lbs

Indications for Late Intervention:

• Aortic diameter >5.5 cm (>5.0 cm in connective tissue disease)
• Rapid expansion >1 cm/year
• Symptoms: Refractory pain, new neurological deficits
• End-organ ischemia

[HIGH_YIELD] Genetic Counseling Indications:

• Age <60 years at presentation
• Family history of aortic disease
• Phenotypic features of connective tissue disorder
• Bicuspid aortic valve or other congenital heart disease

Pregnancy Considerations:

• Type A: Maternal mortality 25-33%
• Type B: Better prognosis with medical management
• Delivery timing: Urgent delivery may be necessary
• Future pregnancies: Generally contraindicated